Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice

Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice

Abstract Background Persistent hepatitis B virus (HBV) infection causes liver cirrhosis and hepatocellular carcinoma and constitutes a major worldwide health problem. Currently, anti-HBV drugs are limited to peginterferon and nucleos(t)ide analogs, which are costly and have considerable side effects...

Full description

Bibliographic Details
Main Authors: Yu-Heng Lai, Cheng-Pu Sun, Hsiu-Chen Huang, Jui-Chieh Chen, Hui-Kang Liu, Cheng Huang
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Complementary and Alternative Medicine
Subjects:
Hepatitis B virus
EGCG
HBsAg
Human liver chimeric mice
Online Access:http://link.springer.com/article/10.1186/s12906-018-2316-4

Internet

http://link.springer.com/article/10.1186/s12906-018-2316-4

Similar Items